Niagen Bioscience
NAGE
53 hedge funds and large institutions have $33.1M invested in Niagen Bioscience in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 9 closing their positions.
134% more capital invested
Capital invested by funds: $14.2M → $33.1M (+$18.9M)
122% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 9
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
26% more funds holding
Funds holding: 42 → 53 (+11)
3.56% more ownership
Funds ownership: 6.85% → 10.41% (+3.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Iconiq Capital
San Francisco,
California
|
+$9.22M |
| 2 |
Millennium Management
New York
|
+$1.11M |
| 3 |
PM
Precept Management
Dallas,
Texas
|
+$1.08M |
| 4 |
Barclays
London,
United Kingdom
|
+$441K |
| 5 |
Renaissance Technologies
New York
|
+$244K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$464K |
| 2 |
VF
Virtu Financial
New York
|
-$272K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$156K |
| 4 |
PHS
Pekin Hardy Strauss
Chicago,
Illinois
|
-$150K |
| 5 |
ECM
Element Capital Management
New York
|
-$139K |
NAGE Hedge Fund Activity: Q4 2017 in Review
53 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q4 2017, worth a combined $33.1M — up 134% from $14.2M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new NAGE positions and 9 closed out — a net gain of 11 holders — while 14 added to existing stakes and 8 trimmed.
The largest buyer was Iconiq Capital, opening a new position worth an estimated $9.22M. The largest seller was North Star Investment Management, cutting an estimated $464K.
- 53 institutional investors held Niagen Bioscience (NAGE) as of Q4 2017, up from 42 in Q3 2017.
- Funds reported $33.1M of Niagen Bioscience stock for Q4 2017, up 134% quarter-over-quarter.
- 20 funds opened new Niagen Bioscience positions in Q4 2017 and 9 closed out, a net change of +11 holders.
- The largest Niagen Bioscience buyer in Q4 2017 was Iconiq Capital, an estimated $9.22M added.
- The largest Niagen Bioscience seller in Q4 2017 was North Star Investment Management, an estimated $464K sold.
Based on aggregated 13F filings for Q4 2017.